APO Research
Talk to an analyst

APO RESEARCH · REPORT

Botanical Drug

Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.

Selected research

Market Analysis & Forecast

Global Botanical Drug Market Analysis and Forecast 2026-2032

28 December 2025192 pages

Choose your research edition.

Industry ResearchBotanical Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Botanical Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Botanical Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Botanical Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Botanical Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.

Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.

Read the full market overview

The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.

Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.

Report Includes

This report presents an overview of global market for Botanical Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Botanical Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Botanical Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Botanical Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Botanical Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Botanical Drug revenue, projected growth trends, production technology, application and end-user industry.

Botanical Drug Segment by Company

Buchang Pharmaceuticals

China TCM

Tsumura

Schwabe

Tong Ren Tang

Jumpcan Pharmaceutical

Guangzhou Baiyunshan Pharmaceutical

Yunnan Baiyao

Tasly Holding Group

Bionorica Se

Huarun 999

Taiji

Weleda

Kwangdong

GW Pharmaceuticals

Botanical Drug Segment by Type

Prescription Drug

OTC

Botanical Drug Segment by Application

Cardiovascular

Tumor

Respiratory System

Others

Botanical Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Botanical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Botanical Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Botanical Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Botanical Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prescription Drug Major Player Table 3. OTC Major Player Table 4. Global Botanical Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cardiovascular Major Player Table 6. Tumor Major Player Table 7. Respiratory System Major Player Table 8. Others Major Player Table 9. Botanical Drug Industry Trends Table 10. Botanical Drug Industry Drivers Table 11. Botanical Drug Industry Opportunities and Challenges Table 12. Botanical Drug Industry Restraints Table 13. Global Botanical Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Botanical Drug Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Botanical Drug Market Share by Region (2021-2026) Table 16. Global Botanical Drug Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Botanical Drug Market Share by Region (2027-2032) Table 18. Global Botanical Drug Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Botanical Drug Revenue Market Share by Players (2021-2026) Table 20. Global Botanical Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Botanical Drug Key Players Headquarters & Area Served Table 22. Global Botanical Drug Players, Product Type & Application Table 23. Global Botanical Drug Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Botanical Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Botanical Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Botanical Drug Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Botanical Drug Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Botanical Drug Revenue Market Share by Type (2021-2026) Table 30. Global Botanical Drug Revenue Market Share by Type (2027-2032) Table 31. Global Botanical Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Botanical Drug Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Botanical Drug Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Botanical Drug Revenue Market Share by Application (2021-2026) Table 35. Global Botanical Drug Revenue Market Share by Application (2027-2032) Table 36. Buchang Pharmaceuticals Company Information Table 37. Buchang Pharmaceuticals Business Overview Table 38. Buchang Pharmaceuticals Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Buchang Pharmaceuticals Botanical Drug Product Portfolio Table 40. Buchang Pharmaceuticals Recent Development Table 41. China TCM Company Information Table 42. China TCM Business Overview Table 43. China TCM Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. China TCM Botanical Drug Product Portfolio Table 45. China TCM Recent Development Table 46. Tsumura Company Information Table 47. Tsumura Business Overview Table 48. Tsumura Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Tsumura Botanical Drug Product Portfolio Table 50. Tsumura Recent Development Table 51. Schwabe Company Information Table 52. Schwabe Business Overview Table 53. Schwabe Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Schwabe Botanical Drug Product Portfolio Table 55. Schwabe Recent Development Table 56. Tong Ren Tang Company Information Table 57. Tong Ren Tang Business Overview Table 58. Tong Ren Tang Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Tong Ren Tang Botanical Drug Product Portfolio Table 60. Tong Ren Tang Recent Development Table 61. Jumpcan Pharmaceutical Company Information Table 62. Jumpcan Pharmaceutical Business Overview Table 63. Jumpcan Pharmaceutical Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Jumpcan Pharmaceutical Botanical Drug Product Portfolio Table 65. Jumpcan Pharmaceutical Recent Development Table 66. Guangzhou Baiyunshan Pharmaceutical Company Information Table 67. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 68. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio Table 70. Guangzhou Baiyunshan Pharmaceutical Recent Development Table 71. Yunnan Baiyao Company Information Table 72. Yunnan Baiyao Business Overview Table 73. Yunnan Baiyao Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Yunnan Baiyao Botanical Drug Product Portfolio Table 75. Yunnan Baiyao Recent Development Table 76. Tasly Holding Group Company Information Table 77. Tasly Holding Group Business Overview Table 78. Tasly Holding Group Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Tasly Holding Group Botanical Drug Product Portfolio Table 80. Tasly Holding Group Recent Development Table 81. Bionorica Se Company Information Table 82. Bionorica Se Business Overview Table 83. Bionorica Se Botanical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Bionorica Se Botanical Drug Product Portfolio Table 85. Bionorica Se Recent Development Table 86. Huarun 999 Company Information Table 87. Huarun 999 Business Overview Table 88. Huarun 999 Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Huarun 999 Botanical Drug Product Portfolio Table 90. Huarun 999 Recent Development Table 91. Taiji Company Information Table 92. Taiji Business Overview Table 93. Taiji Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Taiji Botanical Drug Product Portfolio Table 95. Taiji Recent Development Table 96. Weleda Company Information Table 97. Weleda Business Overview Table 98. Weleda Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Weleda Botanical Drug Product Portfolio Table 100. Weleda Recent Development Table 101. Kwangdong Company Information Table 102. Kwangdong Business Overview Table 103. Kwangdong Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Kwangdong Botanical Drug Product Portfolio Table 105. Kwangdong Recent Development Table 106. GW Pharmaceuticals Company Information Table 107. GW Pharmaceuticals Business Overview Table 108. GW Pharmaceuticals Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. GW Pharmaceuticals Botanical Drug Product Portfolio Table 110. GW Pharmaceuticals Recent Development Table 111. North America Botanical Drug Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Botanical Drug Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Botanical Drug Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Botanical Drug Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Botanical Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Botanical Drug Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Botanical Drug Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Botanical Drug Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Botanical Drug Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Botanical Drug Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Botanical Drug Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Botanical Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Botanical Drug Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Botanical Drug Revenue by Country (US$ Million) & (2027-2032) Table 125. China Botanical Drug Revenue by Type (2021-2026) & (US$ Million) Table 126. China Botanical Drug Revenue by Type (2027-2032) & (US$ Million) Table 127. China Botanical Drug Revenue by Application (2021-2026) & (US$ Million) Table 128. China Botanical Drug Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Botanical Drug Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Botanical Drug Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Botanical Drug Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Botanical Drug Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Botanical Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Botanical Drug Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Botanical Drug Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Botanical Drug Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Botanical Drug Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Botanical Drug Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Botanical Drug Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Botanical Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Botanical Drug Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Botanical Drug Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Botanical Drug Image Figure 2. Global Botanical Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Botanical Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prescription Drug Image Figure 5. OTC Image Figure 6. Global Botanical Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Botanical Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cardiovascular Image Figure 9. Tumor Image Figure 10. Respiratory System Image Figure 11. Others Image Figure 12. Global Botanical Drug Market Size (US$ Million) & (2021-2032) Figure 13. Global Botanical Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Botanical Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Botanical Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Botanical Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Botanical Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Botanical Drug Revenue Market Share by Type (2021-2032) Figure 20. Global Botanical Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Botanical Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Botanical Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Botanical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Botanical Drug Revenue Share by Type (2021-2032) Figure 25. North America Botanical Drug Revenue Share by Application (2021-2032) Figure 26. North America Botanical Drug Revenue Share by Country (2021-2032) Figure 27. United States Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Botanical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Botanical Drug Revenue Share by Type (2021-2032) Figure 32. Europe Botanical Drug Revenue Share by Application (2021-2032) Figure 33. Europe Botanical Drug Revenue Share by Country (2021-2032) Figure 34. Germany Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Botanical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Botanical Drug Revenue Share by Type (2021-2032) Figure 44. China Botanical Drug Revenue Share by Application (2021-2032) Figure 45. Asia Botanical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Botanical Drug Revenue Share by Type (2021-2032) Figure 47. Asia Botanical Drug Revenue Share by Application (2021-2032) Figure 48. Asia Botanical Drug Revenue Share by Region (2021-2032) Figure 49. Japan Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Botanical Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Botanical Drug Revenue Share by Type (2021-2032) Figure 57. SAMEA Botanical Drug Revenue Share by Application (2021-2032) Figure 58. SAMEA Botanical Drug Revenue Share by Country (2021-2032) Figure 59. Brazil Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Botanical Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drug
  • OTC
Applications
  • Cardiovascular
  • Tumor
  • Respiratory System
  • Others
Companies covered
  • Buchang Pharmaceuticals
  • China TCM
  • Tsumura
  • Schwabe
  • Tong Ren Tang
  • Jumpcan Pharmaceutical
  • Guangzhou Baiyunshan Pharmaceutical
  • Yunnan Baiyao
  • Tasly Holding Group
  • Bionorica Se
  • Huarun 999
  • Taiji
  • Weleda
  • Kwangdong
  • GW Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Botanical Drug Market by Type
  3. 1.2.1 Global Botanical Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prescription Drug
  5. 1.2.3 OTC
  6. 1.3 Botanical Drug Market by Application
  7. 1.3.1 Global Botanical Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cardiovascular
  9. 1.3.3 Tumor
  10. 1.3.4 Respiratory System
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Botanical Drug Market Dynamics
  1. 2.1 Botanical Drug Industry Trends
  2. 2.2 Botanical Drug Industry Drivers
  3. 2.3 Botanical Drug Industry Opportunities and Challenges
  4. 2.4 Botanical Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Botanical Drug Market Perspective (2021-2032)
  2. 3.2 Global Botanical Drug Growth Trends by Region
  3. 3.2.1 Global Botanical Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Botanical Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Botanical Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Botanical Drug Revenue by Players
  2. 4.1.1 Global Botanical Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Botanical Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Botanical Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Botanical Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Botanical Drug Key Players Headquarters & Area Served
  7. 4.4 Global Botanical Drug Players, Product Type & Application
  8. 4.5 Global Botanical Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Botanical Drug Market CR5 and HHI
  11. 4.6.3 2025 Botanical Drug Tier 1, Tier 2, and Tier 3
5 Botanical Drug Market Size by Type
  1. 5.1 Global Botanical Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Botanical Drug Revenue by Type (2021-2032)
  3. 5.3 Global Botanical Drug Revenue Market Share by Type (2021-2032)
6 Botanical Drug Market Size by Application
  1. 6.1 Global Botanical Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Botanical Drug Revenue by Application (2021-2032)
  3. 6.3 Global Botanical Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Buchang Pharmaceuticals
  2. 7.1.1 Buchang Pharmaceuticals Company Information
  3. 7.1.2 Buchang Pharmaceuticals Business Overview
  4. 7.1.3 Buchang Pharmaceuticals Botanical Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Buchang Pharmaceuticals Botanical Drug Product Portfolio
  6. 7.1.5 Buchang Pharmaceuticals Recent Developments
  7. 7.2 China TCM
  8. 7.2.1 China TCM Company Information
  9. 7.2.2 China TCM Business Overview
  10. 7.2.3 China TCM Botanical Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 China TCM Botanical Drug Product Portfolio
  12. 7.2.5 China TCM Recent Developments
  13. 7.3 Tsumura
  14. 7.3.1 Tsumura Company Information
  15. 7.3.2 Tsumura Business Overview
  16. 7.3.3 Tsumura Botanical Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Tsumura Botanical Drug Product Portfolio
  18. 7.3.5 Tsumura Recent Developments
  19. 7.4 Schwabe
  20. 7.4.1 Schwabe Company Information
  21. 7.4.2 Schwabe Business Overview
  22. 7.4.3 Schwabe Botanical Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Schwabe Botanical Drug Product Portfolio
  24. 7.4.5 Schwabe Recent Developments
  25. 7.5 Tong Ren Tang
  26. 7.5.1 Tong Ren Tang Company Information
  27. 7.5.2 Tong Ren Tang Business Overview
  28. 7.5.3 Tong Ren Tang Botanical Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Tong Ren Tang Botanical Drug Product Portfolio
  30. 7.5.5 Tong Ren Tang Recent Developments
  31. 7.6 Jumpcan Pharmaceutical
  32. 7.6.1 Jumpcan Pharmaceutical Company Information
  33. 7.6.2 Jumpcan Pharmaceutical Business Overview
  34. 7.6.3 Jumpcan Pharmaceutical Botanical Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Jumpcan Pharmaceutical Botanical Drug Product Portfolio
  36. 7.6.5 Jumpcan Pharmaceutical Recent Developments
  37. 7.7 Guangzhou Baiyunshan Pharmaceutical
  38. 7.7.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  39. 7.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  40. 7.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio
  42. 7.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  43. 7.8 Yunnan Baiyao
  44. 7.8.1 Yunnan Baiyao Company Information
  45. 7.8.2 Yunnan Baiyao Business Overview
  46. 7.8.3 Yunnan Baiyao Botanical Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Yunnan Baiyao Botanical Drug Product Portfolio
  48. 7.8.5 Yunnan Baiyao Recent Developments
  49. 7.9 Tasly Holding Group
  50. 7.9.1 Tasly Holding Group Company Information
  51. 7.9.2 Tasly Holding Group Business Overview
  52. 7.9.3 Tasly Holding Group Botanical Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Tasly Holding Group Botanical Drug Product Portfolio
  54. 7.9.5 Tasly Holding Group Recent Developments
  55. 7.10 Bionorica Se
  56. 7.10.1 Bionorica Se Company Information
  57. 7.10.2 Bionorica Se Business Overview
  58. 7.10.3 Bionorica Se Botanical Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bionorica Se Botanical Drug Product Portfolio
  60. 7.10.5 Bionorica Se Recent Developments
  61. 7.11 Huarun 999
  62. 7.11.1 Huarun 999 Company Information
  63. 7.11.2 Huarun 999 Business Overview
  64. 7.11.3 Huarun 999 Botanical Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Huarun 999 Botanical Drug Product Portfolio
  66. 7.11.5 Huarun 999 Recent Developments
  67. 7.12 Taiji
  68. 7.12.1 Taiji Company Information
  69. 7.12.2 Taiji Business Overview
  70. 7.12.3 Taiji Botanical Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Taiji Botanical Drug Product Portfolio
  72. 7.12.5 Taiji Recent Developments
  73. 7.13 Weleda
  74. 7.13.1 Weleda Company Information
  75. 7.13.2 Weleda Business Overview
  76. 7.13.3 Weleda Botanical Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Weleda Botanical Drug Product Portfolio
  78. 7.13.5 Weleda Recent Developments
  79. 7.14 Kwangdong
  80. 7.14.1 Kwangdong Company Information
  81. 7.14.2 Kwangdong Business Overview
  82. 7.14.3 Kwangdong Botanical Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Kwangdong Botanical Drug Product Portfolio
  84. 7.14.5 Kwangdong Recent Developments
  85. 7.15 GW Pharmaceuticals
  86. 7.15.1 GW Pharmaceuticals Company Information
  87. 7.15.2 GW Pharmaceuticals Business Overview
  88. 7.15.3 GW Pharmaceuticals Botanical Drug Revenue and Gross Margin (2021-2026)
  89. 7.15.4 GW Pharmaceuticals Botanical Drug Product Portfolio
  90. 7.15.5 GW Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Botanical Drug Revenue (2021-2032)
  2. 8.2 North America Botanical Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Botanical Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Botanical Drug Revenue by Type (2027-2032)
  5. 8.3 North America Botanical Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Botanical Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Botanical Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Botanical Drug Revenue by Application (2027-2032)
  9. 8.5 North America Botanical Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Botanical Drug Revenue by Country
  11. 8.6.1 North America Botanical Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Botanical Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Botanical Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Botanical Drug Revenue (2021-2032)
  2. 9.2 Europe Botanical Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Botanical Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Botanical Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Botanical Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Botanical Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Botanical Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Botanical Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Botanical Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Botanical Drug Revenue by Country
  11. 9.6.1 Europe Botanical Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Botanical Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Botanical Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Botanical Drug Revenue (2021-2032)
  2. 10.2 China Botanical Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Botanical Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Botanical Drug Revenue by Type (2027-2032)
  5. 10.3 China Botanical Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Botanical Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Botanical Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Botanical Drug Revenue by Application (2027-2032)
  9. 10.5 China Botanical Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Botanical Drug Revenue (2021-2032)
  2. 11.2 Asia Botanical Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Botanical Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Botanical Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Botanical Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Botanical Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Botanical Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Botanical Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Botanical Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Botanical Drug Revenue by Country
  11. 11.6.1 Asia Botanical Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Botanical Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Botanical Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Botanical Drug Revenue (2021-2032)
  2. 12.2 SAMEA Botanical Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Botanical Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Botanical Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Botanical Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Botanical Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Botanical Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Botanical Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Botanical Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Botanical Drug Revenue by Country
  11. 12.6.1 SAMEA Botanical Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Botanical Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Botanical Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst